Emma Walmsley, GSK CEO (Efren Landaos/Sipa USA/Sipa via AP Images)
GSK remains ‘very confident’ in RSV vaccine amid competition, sales slump
Competition is heating up in the RSV space, despite a lukewarm quarter for vaccine uptake.
Pfizer beat GSK’s Arexvy for the first time in the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
